Strategic Partnerships Add Exclusivity in Leading EHR, e-Prescription, and Technology Companies, Increasing NPI Reach by 37%
OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced four new partner agreements that meaningfully expand the Company’s in-workflow point-of-care (POC) network, fortify its long-term competitive position, and increase total National Provider Identifier (NPI) reach.
The newly executed agreements include:
- An exclusive, multi-year agreement with a high-demand e-prescribing (eRx) platform previously available only through a competitive network
- A new partnership that extends the Company’s presence into the point-of-discharge setting
- Multi-year renewals with two of the Company’s highest-performing electronic health record (EHR) and eRx partners—one of which establishes an exclusive partnership
Together, these agreements significantly expand OptimizeRx’s strategic footprint and reinforce the Company’s leadership in the POC marketing landscape.
With the addition of two new channel partners, OptimizeRx increases its unique NPI reach by 37%. The new partners include an eRx platform that was previously part of a competitive network, and a health systems access partner that reaches HCPs when treatment plans and patient instructions are finalized. The latter partner also provides OptimizeRx with reach into an extended network of EHR platforms, broadening OptimizeRx clients’ access to healthcare providers directly in the clinical workflow.
The renewals strengthen our partnerships with long-term, top-performing EHR and eRx platforms and secure exclusive access to premium inventory. They also increase visibility into future channel revenue, based on the partners’ historical track record of strong utilization, consistent performance, and high ROIs for life sciences brands.
“By deepening relationships with proven, high-value partners and adding exclusive access to large-scale platforms that were previously outside our network, we continue to position the Company for sustained, profitable growth, driven by our clients’ ability to reach a larger audience of relevant providers,” said Steve Silvestro, Chief Executive Officer, OptimizeRx. “Life sciences manufacturers continue to recognize the value of in-workflow engagement for driving brand awareness and conversion. Our network scale, technology assets, and strategic partnerships place us in a strong position to capture growing demand and deliver measurable results for our clients. We believe the steps we are taking today will meaningfully enhance the value we deliver to our clients.”
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!